从海洋皮动物和内生微生物中获得的天然产品的最新进展:化学洞察力和治疗潜力
Shuangyu Li1,2, Yan Xiao2, Qiang Li1
1Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, China.
Marine drugs
|January 24, 2025
概括
称为皮动物的海洋无脊椎动物产生各种自然产品,具有显著的治疗潜力. 最近的研究强调了它们的抗癌和抗微生物化合物,为药物发现提供了新的途径.
科学领域:
- 海洋生物学 海洋生物学
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 皮动物 (海星,海,海黄瓜) 是海洋无脊椎动物.
- 它们是已知的结构多样化的自然产品来源.
- 最近的进展主要集中在分离和评估这些化合物.
研究的目的:
- 审查在过去五年中分离的皮动物的天然产品.
- 突出它们的结构多样性和生物活动.
- 讨论它们的治疗潜力和结构-活动关系.
主要方法:
- 关于过去五年发表的研究的文献综述.
- 对隔离和结构阐明技术的分析.
- 药理学评估和生物活性数据的摘要.
主要成果:
- 识别各种代谢物,包括多糖,三,类固醇和.
- 证明强大的生物活性:抗癌,抗炎,抗病毒和抗菌.
- 为关键化合物建立结构-活性关系.
结论:
- 皮的天然产品为药物发现提供了有价值的支架.
- 需要进一步的研究来克服挑战并探索治疗潜力.
- 对皮动物的持续探索对于海洋药物发现至关重要.
更多相关视频
08:20Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
相关概念视频
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Principles of Drug Action
5.7K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.7K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Prodrugs
2.4K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.4K
